newsfilter
← Latest News
GlobeNewswire·

Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026

  • Ligand Pharmaceuticals Incorporated will report third quarter 2026 financial results on Thursday, October 29, 2026.
  • A conference call to discuss results & provide a business update is scheduled for 8:30 a.m. Eastern time on October 29, 2026.
  • The company holds a diversified royalty portfolio with economic interests in over 200 development & commercial-stage assets.
  • Ligand licenses its proprietary technologies Captisol® & NITRICIL™ to support global drug development.
  • Investor inquiries can be directed to Melanie Herman at investors@ligand.com, while media inquiries go to Kellie Walsh at media@ligand.com.